These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30990966)

  • 41. Encapsulating pH-Responsive Doxorubicin-Phthalocyanine Conjugates in Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Controlled Chemotherapy.
    Wong RCH; Ng DKP; Fong WP; Lo PC
    Chemistry; 2017 Nov; 23(65):16505-16515. PubMed ID: 28771861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-responsive smart cyclodextrin-gated mesoporous silica nanoparticles with ligand-receptor engagement for anti-cancer treatment.
    Wu Y; Xu Z; Sun W; Yang Y; Jin H; Qiu L; Chen J; Chen J
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109831. PubMed ID: 31349481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
    Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
    Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stimuli-Responsive Cucurbit[7]uril-Mediated BSA Nanoassembly for Uptake and Release of Doxorubicin.
    Barooah N; Kunwar A; Khurana R; Bhasikuttan AC; Mohanty J
    Chem Asian J; 2017 Jan; 12(1):122-129. PubMed ID: 27897384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Facile formulation of near-infrared light-triggered hollow mesoporous silica nanoparticles based on mitochondria targeting for on-demand chemo/photothermal/photodynamic therapy.
    Shi CE; You CQ; Pan L
    Nanotechnology; 2019 Aug; 30(32):325102. PubMed ID: 30913541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
    Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Activatable Host-Guest Conjugate as a Nanocarrier for Effective Drug Release through Self-Inclusion.
    Wu H; Wang H; Qi F; Xia T; Xia Y; Xu JF; Zhang X
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33962-33968. PubMed ID: 34279919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cucurbit[8]uril-Based Giant Supramolecular Vesicles: Highly Stable, Versatile Carriers for Photoresponsive and Targeted Drug Delivery.
    Hu C; Ma N; Li F; Fang Y; Liu Y; Zhao L; Qiao S; Li X; Jiang X; Li T; Shen F; Huang Y; Luo Q; Liu J
    ACS Appl Mater Interfaces; 2018 Feb; 10(5):4603-4613. PubMed ID: 29333854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. pH responsive supramolecular prodrug micelles based on cucurbit[8]uril for intracellular drug delivery.
    Wang Y; Li D; Wang H; Chen Y; Han H; Jin Q; Ji J
    Chem Commun (Camb); 2014 Aug; 50(66):9390-2. PubMed ID: 25005141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Label-free tumor cell screening based on IDO1-mediated tryptophan metabolism at single cell level.
    Zhou H; Wen H; Wang L; Xu M; Jia Y; Duan S; Di B; Yu Z; Hu C
    Anal Biochem; 2022 Dec; 659():114936. PubMed ID: 36220375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A multifunctional nanocarrier based on nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular delivery.
    Gao Y; Yang C; Liu X; Ma R; Kong D; Shi L
    Macromol Biosci; 2012 Feb; 12(2):251-9. PubMed ID: 22076739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic Regulation of Thermo-Chemotherapy from a Cucurbit[7]uril-Crosslinked Hybrid Hydrogel.
    Qiao H; Jia J; Chen W; Di B; Scherman OA; Hu C
    Adv Healthc Mater; 2019 Jan; 8(2):e1801458. PubMed ID: 30548830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
    van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
    ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enzyme-Controlled Nanodevice for Acetylcholine-Triggered Cargo Delivery Based on Janus Au-Mesoporous Silica Nanoparticles.
    Llopis-Lorente A; Díez P; de la Torre C; Sánchez A; Sancenón F; Aznar E; Marcos MD; Martínez-Ruíz P; Martínez-Máñez R; Villalonga R
    Chemistry; 2017 Mar; 23(18):4276-4281. PubMed ID: 28220973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Janus Gold Nanostars-Mesoporous Silica Nanoparticles for NIR-Light-Triggered Drug Delivery.
    Hernández Montoto A; Llopis-Lorente A; Gorbe M; M Terrés J; Cao-Milán R; Díaz de Greñu B; Alfonso M; Ibañez J; Marcos MD; Orzáez M; Villalonga R; Martínez-Máñez R; Sancenón F
    Chemistry; 2019 Jun; 25(36):8471-8478. PubMed ID: 31012155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.
    Cheng YJ; Zhang AQ; Hu JJ; He F; Zeng X; Zhang XZ
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2093-2103. PubMed ID: 28032742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.